LOGO 871
Pill imprint LOGO 871 has been identified as Glipizide extended release 2.5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy.
Glipizide 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Glipizide extended release Images
- Imprint:
-
LOGO 871
- Strength:
- 2.5 mg
- Color:
- Blue
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- polyethylene glycol
hypromellose
magnesium stearate
sodium chloride
ferric oxide red
cellulose acetate
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Andrx Pharmaceuticals
- National Drug Code (NDC):
- 62037-0871
Advertisement
More GlipiZIDE Extended Release resources
- Glipizide
- Glipizide (Wolters Kluwer)
- Glipizide Extended-Release Tablets (Wolters Kluwer)
- glipizide (Cerner Multum)
- glipizide (Micromedex) - Includes Dosage Information
- Glipizide (AHFS DI)
- Glipizide (FDA)
- Glipizide ER (FDA)
- Glipizide Tablets (FDA)
- Glipizide (Wolters Kluwer)
Search Again
